Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2005 2
2006 3
2007 3
2008 2
2009 1
2010 2
2011 2
2012 2
2014 2
2015 8
2016 4
2017 3
2018 5
2019 7
2020 4
2021 1
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Results by year
Filters applied: . Clear all
Page 1
Thirty Years of Lactobacillus rhamnosus GG: A Review.
Capurso L. Capurso L. J Clin Gastroenterol. 2019 Mar;53 Suppl 1:S1-S41. doi: 10.1097/MCG.0000000000001170. J Clin Gastroenterol. 2019. PMID: 30741841 Review.
Lactobacillus rhamnosus GG (LGG) was the first strain belonging to the genus Lactobacillus to be patented in 1989 thanks to its ability to survive and to proliferate at gastric acid pH and in medium containing bile, and to adhere to enterocytes. ...The effect
Lactobacillus rhamnosus GG (LGG) was the first strain belonging to the genus Lactobacillus to be patented in 1989 thank
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study.
Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kosikowski W, Szczerbiński M, Gantzel J, Cukrowska B. Skrzydło-Radomańska B, et al. Nutrients. 2020 Jul 5;12(7):1999. doi: 10.3390/nu12071999. Nutrients. 2020. PMID: 32635661 Free PMC article. Clinical Trial.
The purpose of the randomized double-blind placebo-controlled trial was to assess the effectiveness of synbiotic preparation containing probiotic Lactobacillus rhamnosus FloraActive 19070-2, Lactobacillus acidophilus DSMZ 32418, Bifidobacterium lactis DSMZ 32 …
The purpose of the randomized double-blind placebo-controlled trial was to assess the effectiveness of synbiotic preparation containing prob …
Health benefits of Lactobacillus rhamnosus GG and Bifidobacterium animalis subspecies lactis BB-12 in children.
Szajewska H, Hojsak I. Szajewska H, et al. Postgrad Med. 2020 Jun;132(5):441-451. doi: 10.1080/00325481.2020.1731214. Epub 2020 Feb 26. Postgrad Med. 2020. PMID: 32059116 Review.
PURPOSE: To conduct a narrative review that summarizes data on the efficacy and safety of two common probiotic strains - Lactobacillus rhamnosus GG (LGG) and Bifidobacterium animalis subspecies lactis BB-12 (BB-12) - when administered to children. METHODS: Our searc …
PURPOSE: To conduct a narrative review that summarizes data on the efficacy and safety of two common probiotic strains - Lactobacillus
Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
Preston K, Krumian R, Hattner J, de Montigny D, Stewart M, Gaddam S. Preston K, et al. Benef Microbes. 2018 Sep 18;9(5):697-706. doi: 10.3920/BM2017.0105. Epub 2018 Jun 11. Benef Microbes. 2018. PMID: 29888656 Clinical Trial.
A combination of Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 was compared to placebo for relief of symptoms of irritable bowel syndrome (IBS). ...
A combination of Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 w …
Probiotics in Functional Gastrointestinal Disorders.
Hojsak I. Hojsak I. Adv Exp Med Biol. 2019;1125:121-137. doi: 10.1007/5584_2018_321. Adv Exp Med Biol. 2019. PMID: 30578460 Review.
Infantile colic, constipation, functional abdominal pain (FAP), and irritable bowel syndrome (IBS) are the most common functional gastrointestinal disorders (FGID). ...Limited, yet encouraging, evidence exists for Lactobacillus rhamnosus GG (LGG …
Infantile colic, constipation, functional abdominal pain (FAP), and irritable bowel syndrome (IBS) are the most common …
Choosing an appropriate probiotic product for your patient: An evidence-based practical guide.
Sniffen JC, McFarland LV, Evans CT, Goldstein EJC. Sniffen JC, et al. PLoS One. 2018 Dec 26;13(12):e0209205. doi: 10.1371/journal.pone.0209205. eCollection 2018. PLoS One. 2018. PMID: 30586435 Free PMC article.
For example, several types of probiotics had strong evidence for the prevention of antibiotic-associated diarrhea [Saccharomyces boulardii I-745, a three-strain mixture (Lactobacillus acidophilus CL1285, L. casei Lbc80r, L. rhamnosus CLR2) and L. casei DN114001]. .. …
For example, several types of probiotics had strong evidence for the prevention of antibiotic-associated diarrhea [Saccharomyces boulardii I …
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.
Currò D, Ianiro G, Pecere S, Bibbò S, Cammarota G. Currò D, et al. Br J Pharmacol. 2017 Jun;174(11):1426-1449. doi: 10.1111/bph.13632. Epub 2016 Oct 25. Br J Pharmacol. 2017. PMID: 27696378 Free PMC article. Review.
Functional bowel disorders (FBD), mainly irritable bowel syndrome (IBS) and functional constipation (FC, also called chronic idiopathic constipation), are very common worldwide. ...Probiotics, in particular Saccharomyces boulardii and Lactobacilli (amo …
Functional bowel disorders (FBD), mainly irritable bowel syndrome (IBS) and functional constipation (FC, also ca …
The good bugs: the use of probiotics in pediatrics.
Sansotta N, Peroni DG, Romano S, Rugiano A, Vuilleumier P, Baviera G; Italian Society of Pediatric Allergy, Immunology (SIAIP), Microbiota Committee, Italy. Sansotta N, et al. Curr Opin Pediatr. 2019 Oct;31(5):661-669. doi: 10.1097/MOP.0000000000000808. Curr Opin Pediatr. 2019. PMID: 31356353 Review.
RECENT FINDINGS: Strain-specific efficacy was clearly demonstrated with Lactobacillus rhamnosus GG and Saccharomyces boulardii I-745 in the treatment of acute infectious diarrhea, Lactobacillus reuteri DSM 17938 in infantile colics, Lactobacillus rh
RECENT FINDINGS: Strain-specific efficacy was clearly demonstrated with Lactobacillus rhamnosus GG and Saccharomyces boulardii …
Probiotics for induction of remission in Crohn's disease.
Limketkai BN, Akobeng AK, Gordon M, Adepoju AA. Limketkai BN, et al. Cochrane Database Syst Rev. 2020 Jul 17;7(7):CD006634. doi: 10.1002/14651858.CD006634.pub3. Cochrane Database Syst Rev. 2020. PMID: 32678465 Free PMC article.
There is some evidence that probiotics benefit other gastrointestinal conditions, such as irritable bowel syndrome and ulcerative colitis, but their efficacy in CD is unclear. ...One study from Germany had 11 adult participants with mild-to-moderate CD, who w …
There is some evidence that probiotics benefit other gastrointestinal conditions, such as irritable bowel syndrome and …
Probiotics in digestive diseases: focus on Lactobacillus GG.
Pace F, Pace M, Quartarone G. Pace F, et al. Minerva Gastroenterol Dietol. 2015 Dec;61(4):273-92. Minerva Gastroenterol Dietol. 2015. PMID: 26657927 Review.
The present review focuses on three main issues: 1) understanding why, at present, probiotics are so interesting for doctors and consumers; 2) reviewing the available data on probiotic use in digestive diseases, in particular irritable bowel syndrome (IBS), ( …
The present review focuses on three main issues: 1) understanding why, at present, probiotics are so interesting for doctors and consumers; …
51 results